These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6775122)

  • 1. [A comparative study of the relationship between the growth rate of tubercle bacilli and the concentration of antituberculous agents (author's transl)].
    Tsukamura M; Mizuno S
    Kekkaku; 1980 Aug; 55(8):365-70. PubMed ID: 6775122
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of antituberculous chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli (author's transl)].
    Uratsuji Y
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):20-9. PubMed ID: 99201
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. V. Incubating temperature and chemotherapeutic effects. 2 (author's transl)].
    Maekawa N; Ikeda N; Uratsuji Y
    Kekkaku; 1973 Nov; 48(11):913-5. PubMed ID: 4210479
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter I. Bacteriostatic effects (author's transl)].
    Yamadori H
    Kekkaku; 1981 Sep; 56(9):429-33. PubMed ID: 6799690
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)].
    Toyoara M
    Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the growth of tubercle bacilli for the determination of the multi-drug resistance as opposed to several particular drugs].
    Pregowski W; Karczewska L
    Gruzlica; 1971 Aug; 39(8):755-7. PubMed ID: 4999633
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistical aspects of the proportion method for determining the drug-resistance of tubercle bacilli.
    Gálvez-Brandon J; Bartmann K
    Scand J Respir Dis; 1969; 50(1):1-18. PubMed ID: 4980182
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter III. The development of drug resistance (author's transl)].
    Yamadori H
    Kekkaku; 1981 Nov; 56(11):521-4. PubMed ID: 6799686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of low-frequency ultrasound on Mycobacterium tuberculosis].
    Shaĭkhaev AIa; Makarevich NM
    Probl Tuberk; 1989; (10):43-6. PubMed ID: 2512572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the susceptibility to major and minor drugs of tubercle bacilli isolated from 100 consecutive patients never treated with minor drugs.
    Tan THIAM HOK ; The KIE SENG ; Yang SHE YEN ; Tan LIOE SAN
    Paediatr Indones; 1966; 6(2):71-4. PubMed ID: 4960067
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter II. Bactericidal effects (author's transl)].
    Yamadori H
    Kekkaku; 1981 Oct; 56(10):465-70. PubMed ID: 6798295
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G; Koivula T; Hoffner SE
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug activity of bleomycin against tubercle bacilli isolated from pulmonary tuberculous in-patients (author's transl)].
    Endo K
    Jpn J Antibiot; 1973 Dec; 26(6):501-3. PubMed ID: 4131340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

  • 16. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the sensitivity of tubercle bacilli to antibiotics. Technic and results].
    Weill G; Levy A; Guignon JP; Beugnet O; Fuchs J
    Strasb Med; 1965; 16(7):520-42. PubMed ID: 4954387
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ultrastructural study of tubercle bacilli affected by 16 drugs].
    Mei GH
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):209-10. PubMed ID: 6816559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between inoculation size and culture period and the minimum inhibitory concentration of Capreomycin on the growth of Mycobacterium tuberculosis in 1 percent Ogawa's media and Kirchner's semiliquid media with albulin].
    Tamura M; Yamazaki A
    Iryo; 1969 Jul; 23(7):917-22. PubMed ID: 4982095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. IV. Antituberculous activities of R.P in vitro under various inadequate conditions for the growth of tubercle bacilli].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):43-9. PubMed ID: 6442175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.